1-Star Stocks Poised to Plunge: Insulet?

Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, insulin-infusion device specialist Insulet (Nasdaq: PODD  ) has received the dreaded one-star ranking.

With that in mind, let's take a closer look at Insulet's business and see what CAPS investors are saying about the stock right now.

Insulet facts

Headquarters (founded) Bedford, Mass. (2000)
Market Cap $912.6 million
Industry Healthcare equipment
Trailing-12-Month Revenue $152.3 million
Management CEO Duane DeSisto (since 2003)
CFO Brian Roberts (since 2009)
Return on Equity (average, past 3 years) (113.1%)
Cash/Debt $94.0 million / $108.5 million
Competitors Animas
Medtronic
Smiths Medical

Sources: S&P Capital IQ and Motley Fool CAPS.

On CAPS, 37% of the 107 members who have rated Insulet believe the stock will underperform the S&P 500 going forward.

Just last week, one of those Fools, NHWeston, succinctly summed up the bear case for our community:

The future in this space belongs to the company that can make and market "The Artificial Pancreas", the device that simultaneously measures changes in glucose and reponds with an immediate and correct insulin dosage. [Insulet's] problem is that it's up against heavy-weights and [outgunned] by their marketeers. I cannot see it getting bought out. It will, I fear, slip and stagnate.

If you want to retire rich, you need to protect your portfolio from any undue risk. Luckily, we've compiled a special free report for investors called "Discover the Next Rule-Breaking Multibagger," which uncovers another small-cap with big potential. The report is 100% free, but it won't be around forever, so click here to access it now.

Want to see how well (or not so well) the stocks in this series are performing? Follow the TrackPoisedTo CAPS account.

Fool contributor Brian Pacampara owns no position in any of the companies mentioned. The Motley Fool owns shares of Medtronic. Try any of our Foolish newsletter services free for 30 days.

We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Fool's disclosure policy always gets a perfect score.


Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 1854399, ~/Articles/ArticleHandler.aspx, 10/21/2014 5:41:27 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement